Patients with chronic autoimmune conditions who rely on biologic therapies face long wait times, high out-of-pocket costs, and fragmented care. These patients deserve a better standard of care and a clinical experience that feels like it was designed for them — not for the system.

They are not just building better infusion centers. Local Infusion is transforming the infusion market with technology and AI to deliver faster, more affordable, patient-centered care. They are a new care layer between specialist physicians and patients, combining smart software, care navigation, and automation to improve outcomes and lower total costs. Their platform enhances the infusion experience for patients, providers, and payers, positioning Local Infusion as a key infrastructure partner for the next generation of value-based care.

Year partnered
2025
Status
Active
Woody Baum
Founder & CEO
Founder & CEO
Woody Baum
Tcap Team

We started Local Infusion for one simple reason: patients deserve better. When we looked at the infusion landscape, we couldn’t understand why technology and AI, which are transforming nearly every other part of healthcare and daily life, hadn’t yet touched this space. Infusion care was too expensive, too confusing, and too slow. It was everything but what it was meant to be: a pathway to help patients return to their lives. Local Infusion exists to change that by building a platform that improves outcomes, lowers costs, and creates a seamless, personalized experience for patients, providers, and health plans alike. Woody Baum, Founder & CEO

Recent insights from Local Infusion

Insights

'